Menu Back to Latin-America-Regulatory-Conference

Overview

Join global regulators, industry, and academia to engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in Latin America.

DIA brings you a symposium with interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America.

Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.


Need approval in order to attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

Who should attend?

Professionals involved in:

  • Drug Regulation
  • Clinical Research and Development
  • Medical and Scientific Affairs
  • Quality Assurance
  • Research and Development
  • Strategic Sourcing/Planning
  • Regulatory Affairs

Learning objectives

At the completion of this conference, the participant should be able to:
  • Identify the current regulatory landscape across Latin America including updates on harmonization and convergence efforts, and individual regional priorities from various National Regulatory Authorities
  • Discuss how emerging regulatory trends and new technologies impact the development and lifecycle of medical products
  • Establish various approaches and best practices to promote regulatory reliance in Latin America

Program Committee

  • Ana  Padua, MD, MRCP, MSc, RPh
    Ana Padua, MD, MRCP, MSc, RPh Associate Director GRA CMC Regulatory Intelligence Biopharam Global Regulatory
    EMD Serono, Switzerland
  • Maria  Guazzaroni Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director Quality and Regulatory Policy (QRP), Pfizer Global Supply
    Pfizer Inc, United States
  • Maria Cristina  Mota Pina, MBA
    Maria Cristina Mota Pina, MBA Director, Regulatory Policy and Intelligence -Japan, Emerging Markets and Austra
    AbbVie, Inc., United States
  • Juliana  Perlow
    Juliana Perlow Director, Regulatory Affairs-CMC, GRACS CMC – Latin America
    MSD, Brazil
  • Ana Patricia  Pineda, MSc
    Ana Patricia Pineda, MSc International Regulatory Analyst, OIP, OGROP, OC
    FDA, Mexico
  • Analia  Porras
    Analia Porras Unit Chief , Medicines and Health Technologies
    Pan American Health Organization (PAHO), United States
  • Renata  Soares
    Renata Soares Regulation and Health Surveillance Specialist
    Anvisa, Brazil
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download